or
forgot password
  • cancer clinical trials in dallas, TX

  • Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
    University of Texas Southwestern Medical Center UTSW

    Trial Locations
    University of Texas Southwestern Medical Center UTSW
    Texas Oncology, P.A. Texas Onc - Austin
    Baylor College of Medicine Dept. of Sammons Cancer (4)
    Metastatic Renal Cell Carcinoma
    A Study of Intratumoral CAVATAK in Patients With Stage IIIc and Stage IV Malignant Melanoma
    Mary Crowley Cancer Research Centers
    Dallas, Texas 75201
    Malignant Melanoma
    CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
    Baylor Research Institute Baylor Research Institute (17)
    Dallas, Texas 75204
    Chronic Myelogenous Leukemia in Chronic Phase
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Parkland Memorial Hospital

    Trial Locations
    Parkland Memorial Hospital
    Zale Lipshy University Hospital
    University of Texas Southwestern Medical Center
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Juvenile Myelomonocytic Leukemia, Mast Cell Leukemia, Nodal Marginal Zone B-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
    VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
    Dallas, Texas 75216
    Colorectal Cancer
    Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Unspecified Childhood Solid Tumor, Protocol Specific
    The Adv Halt Trial
    UT Southwestern
    Dallas, Texas 75390
    Adenovirus Disease
    Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
    University of Texas Southwestern Medical Center at Dallas
    Dallas, Texas 75235-8897
    Myelodysplastic Syndromes, MDS, RAEB, Chronic Myelomonocytic Leukemia
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Breast Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Texas Oncology

    Trial Locations
    Texas Oncology
    Texas Oncology-Methodist Charlton Cancer Center
    Texas Oncology-Dallas Presbyterian Hospital
    Texas Oncology-Medical City Dallas
    Chronic Myeloid Leukemia
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Phase 1 and 2 Study of PX-866 and Cetuximab
    Mary Crowley Cancer Center

    Trial Locations
    Mary Crowley Cancer Center
    Texas Oncology - Baylor Charles A. Sammons
    Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Non-Small-Cell Lung Carcinoma
    Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
    Ut Southwestern Medical Center
    Dallas, Texas 75390
    Hepatocellular Carcinoma, Liver Cancer
    A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer
    Texas Oncology-Dallas Presbyterian Hospital

    Trial Locations
    Texas Oncology-Dallas Presbyterian Hospital
    Texas Oncology - Medical City Dallas
    Locally Recurrent or Metatastic Breast Cancer ( HER2 Negative)
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Baylor University Medical Center

    Trial Locations
    Baylor University Medical Center
    Parkland Memorial Hospital
    University of Texas Southwestern Medical Center
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Texas Oncology PA

    Trial Locations
    Texas Oncology PA
    Texas Cancer Center - Medical City Dallas
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
    Charles A. Sammons Cancer Center
    Dallas, Texas 75246
    Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma, Marginal Zone Lymphoma
    A Dose Finding Study With Oral LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase (ALK)
    University of Texas Southwestern Medical Center UTSW
    Dallas, Texas 75390-9034
    Tumors Characterized by Genetic Abnormalities of ALK
    Selecting a Favorable KIR Donor in Unrelated HCT for AML
    Baylor Sammons Cancer Center
    Dallas, Texas 75246
    Acute Myelogenous Leukemia
    Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
    Baylor University Medical Center
    Dallas, Texas 75246
    Grade IV Glioma, Grade IV Astrocytoma, Glioblastoma Multiforme
    Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
    University of Texas Southwestern Medical Center
    Dallas, Texas
    GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    US Oncology Central Monitoring

    Trial Locations
    US Oncology Central Monitoring
    Texas Oncology, P.A. Austin Location
    U of TX Southwestern Medical Center - SimmonsCompCancerCtr Clinical Research Office
    Baylor College of Medicine Baylor Texas Oncology
    Non-small Cell Lung Cancer
    A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    Baylor University Medical Center
    Dallas, Texas 75246
    Acute Myeloid Leukemia
    A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer
    Texas Oncology PA North/Sammans Cancer Center
    Dallas, Texas 75246
    HER-2 Gene Amplification
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Texas Oncology - Dallas Presbyterian Hospital

    Trial Locations
    Texas Oncology - Dallas Presbyterian Hospital
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
    Urology Clinics of North Texas, PLLC
    Advanced Prostate Cancer, Prostatic Neoplasms
    Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
    Mary Crowley Cancer Research Center

    Trial Locations
    Mary Crowley Cancer Research Center
    Texas Oncology - Dallas Presbyterian Hospital
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
    Colorectal Cancer
    A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
    Texas Oncology, P.A. Texas Onc - Amarillo

    Trial Locations
    Texas Oncology, P.A. Texas Onc - Amarillo
    Texas Oncology, P.A. Tex Onc 3
    Baylor College of Medicine Baylor Texas Oncology
    Basal Cell Carcinoma